NCT05859165View on ClinicalTrials.gov

To Evaluate Clinical Efficacy and Safety of Diabetes-Specific Formula (Nutren Diabetes)

NARecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

March 18, 2025

Study Completion Date

August 30, 2025

Conditions
Diabetes Mellitus
Interventions
DIETARY_SUPPLEMENT

Nutren Diabetes

Product replace phase: 1-5 days, tube feeding, 25kcal/kg/day Formal intervention phase:7 days, tube feeding, 25kcal/kg/day

DIETARY_SUPPLEMENT

Fresubin Diabetes

Product replace phase: 1-5 days, tube feeding, 25kcal/kg/day Formal intervention phase:7 days, tube feeding, 25kcal/kg/day

Trial Locations (1)

Unknown

RECRUITING

Peking Union Medical College hospital, Beijing

Sponsors

Collaborators (1)

Nestle Health Science
All Listed Sponsors
collaborator

Nestle Health Science

INDUSTRY

lead

Société des Produits Nestlé (SPN)

INDUSTRY

NCT05859165 - To Evaluate Clinical Efficacy and Safety of Diabetes-Specific Formula (Nutren Diabetes) | Biotech Hunter | Biotech Hunter